Treatment of agitation in bipolar disorder across the life cycle
- PMID: 12672259
Treatment of agitation in bipolar disorder across the life cycle
Abstract
Agitation is a common and difficult problem in psychiatric patients; patients with bipolar disorder constitute a substantial proportion of the agitated psychiatric population. Agitation is often seen in bipolar patients during acute manic states, when increased energy levels and reduced need for sleep lead patients to collide with the limits of others. Agitation also occurs during mixed and depressive states, which are characterized by fluctuating energy levels and periods of irritability. Although the prevalence of agitation is similar in men and women, its presentation often differs between the sexes. In addition, the presentations of bipolar disorder in children and in geriatric patients, and thus the manifestations of illness-related agitation, differ both from each other and from that of younger adults. Intensive treatment is required to manage agitated bipolar patients in a manner that rapidly decreases their suffering and maintains their safety and the safety of those around them. Considerations of speed and predictability tend to drive decisions in this setting more than concerns about tolerability. Oral or parenteral benzodiazepines, alone or in combination with an antipsychotic, are recommended as first-line treatment for the termination of behavioral emergencies in mania. Once behavioral control is restored, evidence suggests the combination of orally loaded divalproex sodium with an atypical antipsychotic is associated with more rapid improvement. Medication treatment of children and of geriatric patients must take into account developmental influences on the presentation of bipolar disorder in these different patient groups.
Similar articles
-
Treatments for late-life bipolar disorder.Am J Geriatr Pharmacother. 2006 Dec;4(4):347-64. doi: 10.1016/j.amjopharm.2006.12.007. Am J Geriatr Pharmacother. 2006. PMID: 17296540 Review.
-
Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.J Affect Disord. 2007;100 Suppl 1:S33-43. doi: 10.1016/j.jad.2007.02.005. Epub 2007 Mar 21. J Affect Disord. 2007. PMID: 17376537
-
Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.Am J Geriatr Pharmacother. 2007 Sep;5(3):209-17. doi: 10.1016/j.amjopharm.2007.09.001. Am J Geriatr Pharmacother. 2007. PMID: 17996660 Clinical Trial.
-
Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder.J Psychiatr Pract. 2008 May;14(3):160-9. doi: 10.1097/01.pra.0000320115.38434.16. J Psychiatr Pract. 2008. PMID: 18520785
-
Recognizing and managing bipolar disorder in children.J Clin Psychiatry. 2005;66 Suppl 1:18-23. J Clin Psychiatry. 2005. PMID: 15693748 Review.
Cited by
-
Pharmacokinetics and tolerability of intramuscular, oral and intravenous aripiprazole in healthy subjects and in patients with schizophrenia.Clin Pharmacokinet. 2008;47(7):475-85. doi: 10.2165/00003088-200847070-00004. Clin Pharmacokinet. 2008. PMID: 18563956 Clinical Trial.
-
Inhaled loxapine and intramuscular lorazepam in healthy volunteers: a randomized placebo-controlled drug-drug interaction study.Pharmacol Res Perspect. 2015 Dec 17;3(6):e00194. doi: 10.1002/prp2.194. eCollection 2015 Dec. Pharmacol Res Perspect. 2015. PMID: 27022468 Free PMC article.
-
Response to inhaled loxapine in patients with schizophrenia or bipolar I disorder: PANSS-EC responder analyses.BJPsych Open. 2017 Nov 10;3(6):285-290. doi: 10.1192/bjpo.bp.117.005363. eCollection 2017 Nov. BJPsych Open. 2017. PMID: 29163985 Free PMC article.
-
The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder.Neuropsychiatr Dis Treat. 2006 Jun;2(2):139-48. doi: 10.2147/nedt.2006.2.2.139. Neuropsychiatr Dis Treat. 2006. PMID: 19412458 Free PMC article.
-
Symptomatic response to divalproex in subtypes of conduct disorder.Child Psychiatry Hum Dev. 2011 Oct;42(5):584-93. doi: 10.1007/s10578-011-0234-5. Child Psychiatry Hum Dev. 2011. PMID: 21706221 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical